Apex Sites Fill a Research Gap in the Midst of the US Opioid Crisis and COVID-19 Pandemic

Apex Sites Fill a Research Gap in the Midst of the US Opioid Crisis and COVID-19 Pandemic

As clinical trials are increasingly focusing on patients suffering from the opioid epidemic in the US, Apex sites meet this challenge by investigating such patients’ preferences for various clinical trial designs and site operational issues aimed at enhancing participant retention (a pivotal aspect to trial success) as well as their preferences of such matters specifically during COVID-19.

These data were presented at this year’s International/Canadian Society of Addiction Medicine conference (ISAM-CSAM) which took place November 12-14 and can also be found here: http://www.hritrials.com/participants-retention-2/